Treace Medical Concepts (TMCI) Capital Expenditures Growth (1y) (2021 - 2026)
Treace Medical Concepts (TMCI) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -47.73% |
| 10 | Treace Medical Concepts | 265.48 Mn | 213.62 Mn | 37.41 Mn | -91.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.73% |
| Dec 31, 2025 | 73,311.11% |
| Sep 30, 2025 | -119.87% |
| Dec 31, 2024 | -99.84% |
| Sep 30, 2024 | 105.47% |
| Dec 31, 2023 | -23.53% |
| Sep 30, 2023 | 15.98% |
| Jun 30, 2023 | -18.13% |
| Mar 31, 2023 | -0.20% |
| Sep 30, 2022 | -684.64% |
| Jun 30, 2022 | 671.34% |
| Mar 31, 2022 | 655.61% |
| Sep 30, 2021 | -1,593.10% |
| Jun 30, 2021 | 169.08% |
| Mar 31, 2021 | -70.92% |